Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Berenberg positive on Diageo, Coca-Cola HBC amid tariff uncertainty

(Sharecast News) - Berenberg has given UK-listed drinks stocks Coca-Cola HBC and Diageo a 'buy' rating as part of its review of European beverage brands, as tariff-related newsflow and market volatility continues to dampen sentiment across the sector. "The macro environment has not been kind to the beverages sector. For a sector that behaves like a bond proxy, the rise in the US bond yield from below 1% in early 2021 to the current 4.3% has been devastating for sector valuations," the broker said in a research note on Wednesday.

"However, the macro could be changing, in part thanks to the new Trump Administration and in part to lower inflation. An increased focus on fiscal deficits and lower nominal growth would be much supportive to the beverages sector."

Berenberg highlighted that the European beverages sector is getting closer to a cyclical low after the huge amount of destocking that has happened since late-2023 - a process which it said is still ongoing but affecting spirits companies more than beer producers.

Meanwhile, while tariffs are a serious concern for the industry, especially international spirits companies, the broker said that they should have limited impact on beer and soft drinks groups since their operations are "mostly local in nature".

It added: "However, it is the uncertainty about whether the tariffs are for real, temporary or just part of a negotiating strategy that is arguably worse for share prices."

Regarding UK-listed stocks, Berenberg highlighted Coca-Cola HBC as a key 'buy', saying that its valuation is still low despite the growth trajectory of the business. Diageo is also rated positively, saying it is among the best-placed spirits companies to manage tariff risk.

Share this article

Related Sharecast Articles

GSK gets preliminary nod for two respiratory drugs in Europe
(Sharecast News) - GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines Agency's Committee for Medicinal Products for Human Use, bringing the company closer to potential approvals across severe asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease.
Shore Capital hails improved US biotech funding environment for hVIVO
(Sharecast News) - Shares in AIM-listed hVIVO were continuing their recent surge on the back of encouraging signs from the US biotech market, which broker Shore Capital said has created a "much more favourable environment" for the company.
Weir to buy remaining 50% stake in Chile JV ESEL for £56m
(Sharecast News) - Weir said on Friday that it has agreed to buy the remaining 50% share of its Chile-based joint venture ESEL for a sterling equivalent purchase price of £56m.
Jefferies downgrades Whitbread, upgrades IHG
(Sharecast News) - Jefferies downgraded Whitbread to 'hold' from 'buy' on Friday as it applied the reverse upgrade to InterContinental Hotels.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.